Simplex Trading’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-44,228
Closed 10041
2024
Q4
$0 Buy
44,228
+27,112
+158% +$3.31K ﹤0.01% 9936
2024
Q3
$9K Sell
17,116
-9,176
-35% -$5.14K ﹤0.01% 7295
2024
Q2
$16K Buy
+26,292
New +$22.2K ﹤0.01% 7099
2024
Q1
Sell
-23,172
Closed -$56.6K 10172
2023
Q4
$47K Buy
+23,172
New +$42.3K ﹤0.01% 6140
2023
Q1
Sell
-7,308
Closed -$20.9K 10390
2022
Q4
$25K Sell
7,308
-14,252
-66% -$40.7K ﹤0.01% 6672
2022
Q3
$55K Buy
+21,560
New +$68.6K ﹤0.01% 6320
2022
Q2
Sell
-39,623
Closed -$104K 11371
2022
Q1
$163K Sell
39,623
-19,704
-33% -$104K ﹤0.01% 5449
2021
Q4
$762K Buy
+59,327
New +$657K ﹤0.01% 3246

Simplex Trading's GRTS Position: Q1 2025 in Review

Simplex Trading sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2025, closing a stake of 44,228 shares.

Simplex Trading first reported a position in GRTS in Q4 2021 and held it in 8 quarters. The position peaked at $762K in Q4 2021. 0 funds tracked by Wall St. Rank hold GRTS as of Q1 2025.

  • Simplex Trading reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 44,228 Gritstone bio, Inc. Common Stock shares in Q1 2025.
  • Simplex Trading first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's Gritstone bio, Inc. Common Stock position peaked at $762K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.